"biotech-company"

After having received the government purchase order for 55 lakh doses, Bharat Biotech shipped the first batch of vaccines (each vial containing 20 doses) to Gannavaram, Guwahati, Patna, Delhi, Kurukshetra, Bengaluru

Pfizer said the vaccine had no serious side effects and that the company will apply for emergency use authorization from US regulators "within days"